| ALX-522-060-C050 | 50 µg | 475.00 USD |  |
||
| Do you need bulk/larger quantities? | |||||
| Alternative Name: | TNFRSF 13C, BR3, BlySR3, CD268 |
| MW: | ~40kDa (SDS-PAGE) |
| Source: | Produced in HEK 293 cells. The extracellular domain of human BAFF-R (aa 2-71) is fused at the C-terminus to the Fc portion of human IgG1. |
| UniProt ID: | Q96RJ3 |
| Concentration: | 1mg/ml (after reconstitution) |
| Formulation: | Lyophilized. Contains PBS. |
| Purity: | ≥95% (SDS-PAGE) |
| Endotoxin Content: | <0.1EU/µg purified protein (LAL test; Bio Whittaker). |
| Species reactivity: | Human, Mouse |
| Specificity: | Binds human and mouse BAFF. |
| Applications: | ELISA |
| Application Notes: | ELISA: binds to BAFF. Detection of membrane-bound human and mouse BAFF in combination with PAb to human IgG1. |
| Reconstitution: | Reconstitute with 50µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum or a carrier protein. |
| Shipping: | Shipped on Blue Ice |
| Long Term Storage: | -20°C |
| Use/Stability: | Stable for at least 6 months after receipt when stored at -20°C. |
| Handling: | Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C. |
| Technical Info/Product Notes: | Historical results have shown that BAFF-R inhibits rhsBAFF mediated splenocyte survival. |
| Regulatory Status: | RUO - Research Use Only |
Control:Fc fusion protein (human), (recombinant) |
||||||
| Negative control for Fc chimeric proteins | ||||||
| Produced in HEK 293 cells. The extracellular domain of mutated hThy-1, hThy-1 (RLE) (aa 20-130), is fused to the Fc portion of human IgG1. The integrin binding sequence RLD of hThy-1 has been changed to RLE abolishing the binding of integrins., ≥90% (SDS-PAGE) | Print as PDF | ||||||
| ALX-203-004-C050 | 50 µg | 517.00 USD | |
|||
| Do you need bulk/larger quantities? | ||||||
